StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
ResMed, Inspire Medical slump after Lilly's positive Zepbound data; Citi downgrades
June 24, 2024 9:06 AM
Shares in ResMed (NYSE: RMD) and Inspire Medical Systems (NYSE: INSP) fell sharply in Monday premarket trading, driven by promising ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Analyst PT Change
Downgrades
Hot List
Momentum Movers
Next Articles
Oppenheimer Downgrades ResMed (RMD) to Perform
June 25, 2024 6:02 AM
Eli Lilly (LLY) PT Raised to $1,000 at Truist Securities
June 24, 2024 4:42 PM
ResMed (RMD), Inspire Medical (INSP) sink following Lilly's sleep apnea results
June 24, 2024 8:47 AM